Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates

NCT: NCT06689488 · RECRUITING

NCT IDNCT06689488
StatusRECRUITING
Start Date2025-06-17
Completion2026-12
SponsorCreo Medical Limited (INDUSTRY)
First posted
Last updated

Brief Summary

The overall purpose of this study is to characterise the clinical safety and performance of the Creo Medical MicroBlate™ Flex AB1 instrument in patients with pathologically confirmed malignancy eligible for surgical resection of their nodule, receiving bronchoscopic ablation prior to surgery.

Frequently Asked Questions

What is Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates?

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates is a clinical trial registered under NCT06689488. Current status: RECRUITING.

What is the status of NCT06689488?

The current status of NCT06689488 (Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates) is: RECRUITING.

When did Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates start?

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates started on 2025-06-17.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.